Phase 3 trials across larger and more diverse populations are required before any regulatory submission can be made
This is considered a core mechanism underlying impaired oocyte quality in cycles
Contact your healthcare provider promptly if: Back pain persists beyond 23 weeks despite conservative measures Pain progressively worsens rather than improving Pain significantly interferes with daily activities or sleep Systemic symptoms develop (fever, night sweats) or unintentional weight loss beyond therapy goals Pain occurs in patients with cancer history or other risk factors for metastatic disease Flank pain accompanied by urinary symptoms (possible kidney stones or infection) Clinicians should obtain a thorough history, perform physical examination, and consider laboratory evaluation (including serum lipase and liver function tests) when indicated
It has recently been shown that a PEGylated GLP-1R/GcgR co-agonist could restore leptin sensitivity in DIO mice chronically maintained on a high-fat diet [73], and this may constitute one of the inherent weight-lowering actions of the co-agonist
For GLP-1s specifically, because they tend to have such an outsize impact on prescription spending, its a good idea to have a pharmacist assist in evaluating them
Starting at 0.25mg for 2 weeks also gives you a clear baseline: did you feel anything
